During the Opening Sessions at the National Hemophilia Foundation’s (NHF) 60th Annual Meeting in Denver, Val Bias, NHF CEO, unveiled a new five year, multi-million dollar campaign to achieve the vision: “Access to Care Today, Achieve a Cure Tomorrow.”
Donations will help strengthen NHF’s network of chapters, ensuring that patients in every state have access to the full range of treatment products, high-quality hemophilia treatment centers (HTCs), high standards of care and adequate reimbursement for life-saving therapies. Affinity groups participating in the campaign include NHF chapters, the Board of Directors, MASAC, HTCs, corporations and individuals
To find out more or make adonation, visit Campaign for Our Future.
The Visionary Corporate Partner and Lead Benefactor for the campaign is Novo Nordisk. Other sponsors are: Baxter, Principal Corporate Partner; Bayer, CSL Behring, and Wyeth, Major Corporate Partners; and Grifols, Corporate Partner.